| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | VP Controller | Common Stock | 4.66K | $3.41M | $730.81 | Dec 16, 2024 | Direct |
| REGENERON PHARMACEUTICALS, INC. | VP Controller | Common Stock | 179 | $131K | $730.81 | Dec 16, 2024 | By Trust |
| REGENERON PHARMACEUTICALS, INC. | VP Controller | Common Stock | 11 | $8.04K | $730.81 | Dec 16, 2024 | By 401(k) Plan |
| REGENERON PHARMACEUTICALS, INC. | VP Controller | Non-Qualified Stock Option (right to buy) | 3.24K | Dec 6, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | Dec 16, 2024 | 1 | -$218K | 4 | Dec 18, 2024 | VP Controller |
| REGN | REGENERON PHARMACEUTICALS, INC. | Dec 6, 2024 | 5 | -$117K | 4 | Dec 10, 2024 | VP Controller |
| REGN | REGENERON PHARMACEUTICALS, INC. | Aug 7, 2024 | 3 | -$340K | 4 | Aug 7, 2024 | VP Controller |
| REGN | REGENERON PHARMACEUTICALS, INC. | Feb 6, 2024 | 0 | $0 | 3 | Feb 8, 2024 | Vice President, Controller |